BuChE-IN-1 is a potent butyrylcholinesterase (BuChE) inhibitor with low cytotoxicity and high blood-brain barrier (BBB) permeability, showing promise as a BuChE inhibitor for Alzheimer's disease (AD) research; BuChE has recently been recognized as a biomarker for progressive Alzheimer's disease.